Deep anterior lamellar vs penetrating keratoplasty for macular and granular stromal dystrophies: clinical and refractive results


Sari C., ÇUBUK M. Ö., Ahmet S., Kemer Atik B., Kandemir Besek N., KIRGIZ A.

BMC Ophthalmology, cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 1
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1186/s12886-026-05105-z
  • Dergi Adı: BMC Ophthalmology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
  • Anahtar Kelimeler: Cornea, Keratometry, Lamellar keratoplasty, Penetrating keratoplasty, Stromal dystrophy
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: To evaluate and compare visual, refractive, and keratometric outcomes and complications in patients who underwent Deep Anterior Lamellar Keratoplasty (DALK) and Penetrating Keratoplasty (PKP) surgery for stromal corneal dystrophies. Methods: This retrospective study included 35 eyes that underwent keratoplasty for stromal corneal dystrophy. The eyes were divided into 4 groups according to dystrophy type and surgical procedure. Results: In the macular corneal dystrophy (MCD) group, 13 PKP, 6 DALK; in the granular corneal dystrophy (GCD) group, 10 PKP, 6 DALK surgeries were performed. Compared to the preoperative period, there was a significant increase in BCVA at 1 year postoperatively for all groups (p < 0.05). 1-year graft survival after PKP was 84.6% and 100% in the MCD and GCD groups, respectively. Whereas it was 83.3% after DALK in both groups. Two cases of endothelial graft rejection occurred in the MCD-PKP group, while one case of stromal graft rejection was observed in the MCD-DALK group. Additionally, one instance of disease recurrence was seen in each of the following groups: MCD-PKP, MCD-DALK, and GCD-DALK. Conclusion: These findings suggest that DALK may provide acceptable visual, refractive, and graft survival outcomes in selected patients with stromal corneal dystrophies. Given its closed-sky surgical nature and lower risk of endothelial rejection, DALK may be considered a suitable alternative to PKP in appropriately selected cases.